Verge Genomics news
Take a listen as our CEO Alice Zhang is featured on the Fierce Biotech "The Top Line" podcast (5:58-7:57) sharing where she expects Verge to be 10 years after being selected as a 2022 #Fierce15 winner.
The executive spoke with BioPharma Dive about the challenges she’s faced winning over investors and building a drug startup.
Published Oct. 25, 2022
Gwendolyn Wu
The mad scramble to adopt Artificial Intelligence amid the Covid-19 crisis is officially old news. We interact with AI as seamlessly as we do our smartphones, through voice assistants, customer service, automated tasks, self-checkout, fraud detection, in healthcare decisions and infinitely more invisible applications that affect our daily lives. Investments in
The treatment development company Verge Genomics — known for its all-in-human artificial intelligence platform — has been named among the “Fierce 15” by daily email newsletter Fierce Biotech.
Verge’s inclusion by the web resource in the 20th annual Fierce 15 listing, announced in a